(Q43031174)

12 November 2017

title

Variations within hepatitis C virus E2 protein and response to interferon treatment (English)

1 reference

12 November 2017

1 reference

Lo S

1

1 reference

12 November 2017

Lin HH

series ordinal

2

1 reference

12 November 2017

publication date

1 June 2001

1 reference

12 November 2017

1 reference

12 November 2017

volume

75

1 reference

12 November 2017

issue

2

1 reference

12 November 2017

page(s)

107-112

1 reference

Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Prediction of response to interferon treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Genotypes of hepatitis C virus in Taiwan and the progression of liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Clinical and histologic predictors of response to interferon-alpha in patients with chronic hepatitis C viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Vaccines to prevent viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Hepatitis C virus dynamics in vivo and the antiviral efficacy of interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

The first Flaviviridae symposium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900224-6

7 January 2021

10.1016/S0168-1702(01)00224-6

Identifiers

DOI

1 reference

release_llhp7awdkndrjii5o3xhh5wbby

12 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/llhp7awdkndrjii5o3xhh5wbby

24 November 2022

mapped directly with Wikidata item

1 reference